Skip to Main Content

Paper Details

Drug-adapted cancer cell lines as preclinical models of acquired resistance.
Cancer Drug Resist
27
2019
Author NameAffiliation
Mark N WassUniversity of Kent
  • 1 - 1

Datasets

Release 1.2